M&AHealthcareSIGNED
Webster Equity Partners Inks $664 Million Take-Private of Lifecore Biomedical
Value
$664M
Acquirer
Webster Equity Partners
Target
Lifecore Biomedical
Webster Equity Partners has agreed to acquire Lifecore Biomedical in a take-private transaction valued at $664 million. Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in sterile injectable drugs.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.